Jim Tananbaum is the CEO and Founder of Foresite Capital. He founded Foresite back in 2011 as a private equity firm dedicated to healthcare and specializing in the identification of emerging healthcare leaders. His firm helps emerging healthcare leaders grow to profitability by supplying them with information, networks, and capital.
Before founding Foresite Capital, Mr. Jim Tananbaum co-founded two healthcare investment practices and two biopharmaceutical companies. Jim founded GelTex Pharmaceuticals, which for not more than $80 million introduced two drugs on to the market. In 1998, GelTex was acquired for approximately $1.6 billion when Renagel (Renzela), its lead drug attained an annual run rate revenue of over $200 million. Presently, Renzela is approximated to produce about $1 billion in revenue annually. He also co-founded Theravance, Inc and held the position of CEO.
Mr. Tananbaum’s investment experience is very vast, reveals Medium.com. He is Prospect Venture Partners II & III’s founding partner. Additionally, he helped Sierra Ventures set up its healthcare investment practice services. He has led several investments such as the Amerigroup NASDAQ: AMGP, Amira Pharmaceuticals, Jazz Pharmaceuticals NASDAQ: JAZZ, and Healtheon NASDAQ:WBMD. When founding Foresite Capital, Jim had the vision of bringing together all elements of his career to come up with a novel investment platform.
At Yale, Jim was an electrical engineering and math major. He received his MBA and MD from Harvard. He also holds an MS from the Massachusetts Institute of Technology. Ever since Jim was in high school, he has been zealous about the marriage of computer science and interdisciplinary hard sciences with healthcare. Jim has had quite a number of long-term productive relationships with various leading academicians.
His collaborators including George Whitesides (Harvard), Roy Vagelos (Merck and Theravance), Rick Klausner (NCI), Rick Levin (Yale), and Bob Gunderson (Gunderson Detmer) have been his mentors. Mr. Tananbaum is passionate about carrying on with his evolution of working on fields with leading academicians and entrepreneurs.
According to Jim Tananbaum, bringing ideas to life doesn’t involve capital only. It requires engaging the most effective, smartest, and persistent leaders in healthcare. His business involves providing these people with means to aid in their critical scientific discoveries.